CAS RN: 2639939-72-1

1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin, 4,4,8,8-tetrakis(3,5-diethylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-, (3aS,8aS)-

Product Availability

Choose a grade to view its available package options.

5 package records3 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250515 100mg In stock Shanghai, Tianjin, Wuhan, Chengdu Inquiry
Batchno.20250430 100mg / 250mg / 1g Out of stock 8-10 business days Inquiry
Batchno.20260105 1g In stock Shanghai, Tianjin, Wuhan, Chengdu Inquiry
Batchno.20260610 250mg In stock Shanghai, Shenzhen, Tianjin, Wuhan, Chengdu Inquiry
Batchno.20250220 5g Out of stock Inquiry
  • Product code: starshine_CAS2639939-72-1
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

2639939-72-1 / (3aS,8aS)-4,4,8,8-tetrakis(3,5-diethylphenyl)-2,2-dimethyl-6-phenyl-3a,8a-dihydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine

Standard CAS: 2639939-72-1 Multi CAS: No

Basic Information

CAS
2639939-72-1
Multi CAS
No
Molecular Formula
C53H65O4P
Molecular Weight
797.100000
Exact Mass
796.462048
SMILES
CCC1=CC(=CC(=C1)C2([C@@H]3[C@@H](C(OP(O2)C4=CC=CC=C4)(C5=CC(=CC(=C5)CC)CC)C6=CC(=CC(=C6)CC)CC)OC(O3)(C)C)C7=CC(=CC(=C7)CC)CC)CC
InChI
InChI=1S/C53H65O4P/c1-11-36-24-37(12-2)29-44(28-36)52(45-30-38(13-3)25-39(14-4)31-45)49-50(55-51(9,10)54-49)53(46-32-40(15-5)26-41(16-6)33-46,47-34-42(17-7)27-43(18-8)35-47)57-58(56-52)48-22-20-19-21-23-48/h19-35,49-50H,11-18H2,1-10H3/t49-,50-/m0/s1
InChIKey
BNAMLZQDVVNLSE-WLTNIFSVSA-N

Computed Properties

Structural Parameters

Heavy atom count
58
Aromatic heavy atom count
30
Fraction Csp3
0.43
Rotatable bonds
13
H-bond acceptors
4
Molar refractivity
241.34
TPSA
36.92

LogP / Solubility

WLOGP
12.58
MLOGP
11.14
XLogP3
14.1
Consensus LogP
12.61
Log S (ESOL)
-12.23
Class (ESOL)
Insoluble
Log S (Ali)
-15.18
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-16.84
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
1.35

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
7

Get In Touch

Contact Us